arrow_back Back Filing freshness 10-Q Q2 FY2026 SEC EDGAR

Orthofix Medical Inc.

OFIX
$9.00 ▲ +0.05 (+0.56%) at close
Healthcare ·Surgical & Medical Instruments & Apparatus ·USSurgical & Medical Instruments & Apparatus
68 Visible periods
32 Metrics
Peer-ranked Benchmarks
Price Chart
30
Health
Poor
Bearish
auto_awesome

Analytical Summary

Orthofix Medical Inc. faces fundamental challenges with weakness in Profit Margin (%) and Operating Margin (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $368.2M
Dividend Yield
Revenue Growth 3.8%
Op. Margin -3.9%
ROIC -1.3%
FCF / Share $-0.15
Trailing P/E
Price / Book 0.9x
FCF Yield
Debt / Equity 0.52
info Valuation on last close. End-of-day price, Sep 22, 2026.

68-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$210.93M
↑ +3.8%
Net Income Profit after all expenses
$-20.91M
↑ +60.6%
Operating Margin Operating profit as % of sales
-3.9%
↑ +47.5% 15th
FCF / Share Free cash flow per share
$-0.15
↑ +65.1%
Long-Term Debt Long-term obligations
$221.59M
— +0.1%
trending_up

Bullish Indicators

  • No bullish signals detected.
warning

Bearish Risks

  • Operating Margin (%)Operating Margin (%) is in the bottom quartile
  • Profit Margin (%)Profit Margin (%) is in the bottom quartile

Health Breakdown

Profitability
24
Returns
27
Financial Health
49
Cash Quality
14

bar_chart Data from SEC EDGAR XBRL filings

Synced yesterday 18 years · 68 quarters